{"id":"https://openalex.org/W3082965619","doi":"https://doi.org/10.1080/24725625.2020.1816674","title":"Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies","display_name":"Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies","publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3082965619","doi":"https://doi.org/10.1080/24725625.2020.1816674","mag":"3082965619","pmid":"https://pubmed.ncbi.nlm.nih.gov/32867615"},"language":"en","primary_location":{"id":"doi:10.1080/24725625.2020.1816674","doi":"https://doi.org/10.1080/24725625.2020.1816674","is_oa":false,"landing_page_url":"https://doi.org/10.1080/24725625.2020.1816674","pdf_url":null,"source":{"id":"https://openalex.org/S4210214405","display_name":"Modern Rheumatology Case Reports","issn_l":"2472-5625","issn":["2472-5625"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Modern Rheumatology Case Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077846765","display_name":"Shin\u2010ichiro Ohmura","orcid":"https://orcid.org/0000-0001-8651-4149","observed_orcids":["https://orcid.org/0000-0001-8651-4149"]},"institutions":[{"id":"https://openalex.org/I4210130594","display_name":"Seirei Hamamatsu General Hospital","ror":"https://ror.org/036pfyf12","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210130594"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-ichiro Ohmura","raw_affiliation_strings":["Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan","institution_ids":["https://openalex.org/I4210130594"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toru Yamabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33858575","display_name":"Nagoya City University","ror":"https://ror.org/04wn7wc95","country_code":"JP","type":"education","lineage":["https://openalex.org/I33858575"]},{"id":"https://openalex.org/I4210115105","display_name":"Nagoya City University Hospital","ror":"https://ror.org/02adg5v98","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210115105"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toru Yamabe","raw_affiliation_strings":["Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan","Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan","institution_ids":["https://openalex.org/I33858575"]},{"raw_affiliation_string":"Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan","institution_ids":["https://openalex.org/I4210115105"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039430766","display_name":"Taio Naniwa","orcid":"https://orcid.org/0000-0002-0489-2611","observed_orcids":["https://orcid.org/0000-0002-0489-2611"]},"institutions":[{"id":"https://openalex.org/I33858575","display_name":"Nagoya City University","ror":"https://ror.org/04wn7wc95","country_code":"JP","type":"education","lineage":["https://openalex.org/I33858575"]},{"id":"https://openalex.org/I4210115105","display_name":"Nagoya City University Hospital","ror":"https://ror.org/02adg5v98","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210115105"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Taio Naniwa","raw_affiliation_strings":["Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan","Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0489-2611","affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan","institution_ids":["https://openalex.org/I33858575"]},{"raw_affiliation_string":"Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan","institution_ids":["https://openalex.org/I4210115105"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5039430766"],"corresponding_institution_ids":["https://openalex.org/I33858575","https://openalex.org/I4210115105"],"apc_list":{"value":1071,"currency":"USD","value_usd":1071},"apc_paid":null,"fwci":2.542,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.90136396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"5","issue":"1","first_page":"76","last_page":"81"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/anti-mda5-antibody","display_name":"anti-MDA5 antibodies","score":0.8989999890327454},{"id":"https://openalex.org/keywords/amyopathic-dermatomyositis","display_name":"amyopathic dermatomyositis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.859000027179718},{"id":"https://openalex.org/keywords/rapidly-progressive-interstitial-lung-disease","display_name":"rapidly progressive interstitial lung disease","score":0.9110000133514404},{"id":"https://openalex.org/keywords/refractory-dermatomyositis","display_name":"refractory dermatomyositis","score":0.824999988079071},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/calcineurin-inhibitors","display_name":"calcineurin inhibitors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8289999961853027},{"id":"https://openalex.org/keywords/glucocorticoids","display_name":"glucocorticoids","score":0.906000018119812},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7609439492225647},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5790284872055054},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4465923011302948},{"id":"https://openalex.org/C2778751314","wikidata":"https://www.wikidata.org/wiki/Q681160","display_name":"Dermatomyositis","level":2,"score":0.4133723974227905},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32447075843811035}],"mesh":[{"descriptor_ui":"D000072640","descriptor_name":"Interferon-Induced Helicase, IFIH1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003882","descriptor_name":"Dermatomyositis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003882","descriptor_name":"Dermatomyositis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017563","descriptor_name":"Lung Diseases, Interstitial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017563","descriptor_name":"Lung Diseases, Interstitial","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/24725625.2020.1816674","doi":"https://doi.org/10.1080/24725625.2020.1816674","is_oa":false,"landing_page_url":"https://doi.org/10.1080/24725625.2020.1816674","pdf_url":null,"source":{"id":"https://openalex.org/S4210214405","display_name":"Modern Rheumatology Case Reports","issn_l":"2472-5625","issn":["2472-5625"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Modern Rheumatology Case Reports","raw_type":"journal-article"},{"id":"pmid:32867615","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32867615","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Modern rheumatology case reports","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1788311176","https://openalex.org/W2007995332","https://openalex.org/W2029016041","https://openalex.org/W2035320881","https://openalex.org/W2036685480","https://openalex.org/W2069302785","https://openalex.org/W2102934414","https://openalex.org/W2117941014","https://openalex.org/W2148709599","https://openalex.org/W2149447280","https://openalex.org/W2153414586","https://openalex.org/W2164858045","https://openalex.org/W2336194645","https://openalex.org/W2344698209","https://openalex.org/W2416097871","https://openalex.org/W2611548364","https://openalex.org/W2613311251","https://openalex.org/W2794685813","https://openalex.org/W2800751803","https://openalex.org/W2810967244","https://openalex.org/W2884167081","https://openalex.org/W2903492331","https://openalex.org/W2906724980","https://openalex.org/W2961094118","https://openalex.org/W2979984526","https://openalex.org/W4211050134"],"related_works":["https://openalex.org/W4313406819","https://openalex.org/W2884167081","https://openalex.org/W4281984366","https://openalex.org/W3137831907","https://openalex.org/W4400482373","https://openalex.org/W3156456102","https://openalex.org/W3085036241","https://openalex.org/W4380849014","https://openalex.org/W4403939013","https://openalex.org/W4410587415"],"abstract_inverted_index":{"Anti-melanoma":[0],"differentiation-associated":[1],"gene":[2],"5":[3],"(MDA-5)":[4],"antibodies":[5],"have":[6,59],"widely":[7],"known":[8],"to":[9,38,89,106],"be":[10,67],"associated":[11,83],"with":[12,15,27,64],"amyopathic":[13],"dermatomyositis":[14,81],"rapidly":[16,42],"progressive":[17,43],"interstitial":[18],"lung":[19],"disease":[20],"(ILD).":[21],"Although":[22],"the":[23,45,90,102],"triple":[24,91],"combination":[25,62],"therapy":[26,63,92],"high-dose":[28],"glucocorticoids,":[29],"cyclophosphamide,":[30],"and":[31,82,93],"a":[32,76],"calcineurin":[33],"inhibitor":[34],"has":[35],"been":[36],"used":[37],"treat":[39],"anti-MDA-5":[40,79],"antibody-positive":[41,80],"ILD,":[44],"prognosis":[46],"of":[47,78,104],"these":[48],"patients":[49],"remains":[50],"poor":[51],"despite":[52],"this":[53],"intensive":[54],"therapy.":[55],"Recently,":[56],"several":[57],"investigators":[58],"shown":[60],"that":[61],"tofacitinib":[65,94,105],"might":[66],"potentially":[68],"efficacious":[69],"in":[70],"those":[71],"patients.":[72],"We":[73],"herein":[74],"report":[75],"case":[77],"ILD":[84],"who":[85],"had":[86],"not":[87],"responded":[88,99],"10":[95],"mg/day":[96],"but":[97],"markedly":[98],"after":[100],"increasing":[101],"dose":[103],"20":[107],"mg/day.":[108]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-09-08T00:00:00"}